Empagliflozin Ameliorates Diastolic Dysfunction and Left Ventricular Fibrosis/Stiffness in Nondiabetic Heart Failure
Carlos G. Santos‐Gallego, Juan Antonio Requena-Ibáñez, Rodolfo San Antonio, Álvaro García‐Ropero, Kiyotake Ishikawa, Shin Watanabe, Belén Picatoste, Ariana P. Vargas-Delgado, Eduardo Flores‐Umanzor, Javier Sanz, Valentı́n Fuster, Juan J. Badimón
Topics & Concepts
EmpagliflozinCardiologyInternal medicineMedicineDiastoleHeart failureFibrosisPreloadHemodynamicsDiabetes mellitusBlood pressureEndocrinologyType 2 Diabetes MellitusCardiovascular Function and Risk FactorsCardiac Fibrosis and RemodelingCongenital heart defects research